MedTrace Logo

Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer

NCT03045575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2020-07-02

No results posted yet for this study

Summary

This is a prospective observational study designed to determine the feasibility and acceptability of objectively measuring physical activity, sedentary time, and sleep using the Fitbit Charge HR wristband. 50 patients who have been diagnosed with breast cancer and are planning to initiate chemotherapy will be invited to participate in this study, and we will measure general and breast-specific quality-of-life using Patient-Reported Outcomes Measurement Information System (PROMIS) measures for 3-6 months after completion of chemotherapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Michelle Melisko, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-02
Primary Completion
2018-01-18
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045575 on ClinicalTrials.gov